Status:
UNKNOWN
Imaging vs. no Testing in Asymptomatic High-risk Diabetic Patients
Lead Sponsor:
Clinical Centre of Serbia
Conditions:
Asymptomatic
High Risk
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
The aim of our study was to evaluate 1- and 3-year outcome of alternative imaging strategies in asymptomatic high-risk diabetic patients: functional stress echocardiography combined with coronary flow...
Detailed Description
A meta-analysis of \>100 prospective studies, showed that diabetes mellitus (DM) in general carries a two-fold excess risk of vascular outcomes (coronary artery disease, ischemic stroke, and vascular ...
Eligibility Criteria
Inclusion
- Asymptomatic patients (\>30 years) with duration of diabetes ≥10 years without target organ damage plus any other additional risk factor including age, hypertension, dyslipidemia, smoking, and obesity.
Exclusion
- Patient categorized as very high or moderate risk for CV diseases
- Any symptoms suggestive of angina or heart failure
- Patients with baseline ECG or echo abnormalities
- Patients with known CV disease, or previous myocardial revascularization
- Patients with target organ damage defined as proteinuria, renal impairment defined as eGFR \<30 mL/min/1.73 m2, left ventricular hypertrophy, or retinopathy
Key Trial Info
Start Date :
January 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04388280
Start Date
January 28 2021
End Date
December 31 2023
Last Update
August 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Centre of Serbia
Belgrade, Serbia, 11000